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Background & objectives: Congenital rubella syndrome (CRS) accounts for a significant amount of
mortality and morbidity in India. Rubella vaccination is not included in our national immunization
programme. Occupational exposure of the health care personnel to rubella infection is well known.
This study aims to assess the serological status of health care workers against rubella virus in
Aravind Eye Care System, Madurai and to follow the immune response in the seronegative
individuals after vaccination.
Methods: A total of 500 female and 81 male workers were enrolled in the study. Blood sample was
collected for the analysis of rubella specific IgM and IgG antibodies. The seronegative individuals
were vaccinated with monovalent rubella vaccine, RA 27/3. The post-vaccination samples were
analysed for the antibody levels and their avidity using enzyme immunoassay.
Results: Of the 581 volunteers, 493 were seropositive with good protective immunity and 22 had
both IgM and IgG antibodies. Sixty six volunteers (59 females and 7 males) were found to be
seronegative to rubella. The seroconversion was observed in all the sixty vaccinated individuals, as
seen by the appearance of anti-rubella IgG antibodies by fourth week, reaching the peak protective
levels (>20 IU/ml) by third month. There was also a progressive increase in the avidity after
vaccination.
Interpretation & conclusion: Nearly 11.4 per cent of the health care workers were found to be
seronegative for rubella virus and after vaccination, these volunteers developed a good
protective immunity, thereby reducing the risk of contracting the hospital based rubella
infection. Therefore, rubella vaccination may be instituted in hospitals for the benefit of health
care workers.
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Primary acquired rubella infection in the first
three months of pregnancy can cause severe
congenital malformations in the foetus and also
delayed complications in later life, collectively
known as congenital rubella syndrome (CRS)1,2. It
was observed that 25 per cent of congenital cataracts
in children in south India were due to maternal
rubella, 50 per cent infants were found to have
cardiovascular anomalies and 34.8 per cent infants
attending the pediatric department of Aravind Eye
Care System (AECS) had developmental and
neurological defects3,4.
The outbreak of rubella in Europe and United
States (1962-1965) highlighted the importance of
developing rubella vaccine in 1969 to prevent the
foetal infection and the consequent CRS5. In many
developing countries including India, rubella
vaccination is not a part of national immunization
programme but is available through the private sector
in the combined measles-mumps-rubella (MMR)
vaccine5.
Occupational exposure of the health care
personnel to rubella infection deserves special
attention. Non-immune pregnant women are at a risk
of contracting the infection from patients. Infected
health care workers can also act as a potential vectors
in the transmission of the virus6.
Rubella specific IgG begins to rise after the onset
of rash, peaks at about 4 wk and lasts for life, serving
as a long term marker for protective immunity7.
Serosurvey studies among the hospital personnel
from various countries showed that 2.4-36.3 per cent
of the female health care workers were seronegative
against rubella and were at the risk of acquiring
infection6,8-12.  In Songklanagarind University
Hospital, Thailand, a total of 366 health care
personnel (256 female and 110 male) were tested for
rubella antibodies by haemagglutination inhibition
(HAI) test, of which 36.3 per cent of females were
found to be seronegative. Vaccination resulted in 100
per cent seroconversion11. In India, a hospital based
rubella outbreak was reported in 1990 from St. John’s
Medical College and Hospital Campus, Bangalore,
where 7 of the 12 female workers (medical students,
nurse and staff) did not have rubella specific IgG
antibodies at the time of onset of illness13. In a study
on seroprevalence of rubella involving 580 women
including 80 of medical community at Amritsar
district (Punjab), India, 20 per cent were found to be
susceptible with risk of acquiring rubella infection14.
Non-immune pregnant women are also susceptible
for rubella infection from unimmunized men15.
Nearly 20.9 per cent of susceptibility rate was
reported among male health workers in Thailand11.
In 2002, a serosurvey study was conducted
among the female health care workers of AECS, India
and reported 15 per cent seronegativity16. The present
investigation was designed to carry out serosurvey
on the rubella immune status among both male and
female health care workers in AECS, Madurai, to
follow the immune status of the seronegative
individuals after vaccination and also to determine
the avidity index of the anti-rubella antibody.
Material & Methods
Study subjects: The study was conducted between
July 2004 and May 2005 among the newly joined
health care workers (Table). They were given
adequate background information of the study and
those volunteered with a written consent were
enrolled. A total of 500 female and 81 male health
care personnel between 15-40 yr of age working in
different departments of AECS, Madurai, were
screened. The Institutional Review Board of AECS
approved the study. Details of the information of
marital status, immunization history, type and
duration of employment were obtained for analysis
using a well designed questionnaire.
Collection of blood sample: Two ml of blood
specimen was collected from each participant. Serum
was separated and stored as aliquots in -70oC.
Samples to be used immediately were stored at
-20oC.
Detection of seronegativity: Rubella specific IgM and
IgG antibodies were detected by enzyme linked
immunosorbent assay (ELISA) using the Euroimmun
Kit (Medizinische Labordiagnostika AG, Lubeck)
according to the manufacturer’s instruction. The
results were interpreted as seronegative if the ratio
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of the extinction value was less than 0.8 and
seropositive if more than 1.1. Samples with the ratio
between 0.8 - 1.1 were considered equivocal and
retested using a fresh blood sample. Validation of
the kit was carried out using the Quality Control
samples from Aravind Eye Hospital, India, and
Health Protection Agency, London. All participants
were duly informed of the results. The samples from
those cases that were positive for both IgM and IgG
antibodies (n =22) were collected again after 4
months for retesting with the Euroimmun kit.
Vaccination of seronegative workers :  Sixty
seronegative individuals (55 female and 5 male) were
given a single dose of rubella vaccine and the married
females were advised to avoid conception for three
months following vaccination17. The RA 27/3 rubella
vaccine (Serum Institute of India, Pune) was
reconstituted with diluent supplied by the
manufacturer and administered intramuscularly.
Antibody titre after vaccination: Blood samples from
the vaccinated individuals were obtained at first and
fourth week, third and sixth month, and their sera
were analysed for IgM and IgG antibodies. The
Visual Basic programme, developed by using the
algorithm specified in the Euroimmun kit, was used
for quantification of IgG antibodies in International
Unit per ml (IU/ml).
Avidity index: Sera collected at the end of first, third
and sixth month were analysed for avidity by
Euroimmun IgG Avidity Kit (Medizinische
Labordiagnostika AG, Lubeck).The assay was based
on protein denaturing avidity principle using urea as
a protein denaturant. The samples were assigned as
high avidity if the avidity index was > 60 per cent
and low avidity if < 40 per cent. The avidity index
between 40-60 per cent was considered as equivocal.
Statistical analysis: The data were double-entered in
Epi Info, version 6.04 (Centers for Disease Control
and Prevention, Atlanta, GA, USA and WHO,
Geneva, Switzerland). Analysis and representation
of the data was carried out using Stata, version 7.0
(Stata Corporation, College Station, TX, USA)
software and Microsoft Excel. The data were tested
using Mann Whitney Rank Sum test with a
significance level of 0.05. Repeated measures of
ANOVA has been employed for testing the
differences in mean avidity index among three time
periods.
Results
Anti-rubella antibody profile: Of the 581 personnel
tested, IgG anti-rubella antibody was observed in 493
and both IgM and IgG antibodies in 22 personnel.
However, 66 were negative for both IgM and IgG
antibodies.  Seronegativity was high among the
laboratory/research staff and physicians and lowest
among housekeepers/caterers (Table). The proportion
of seronegativity was 11.8 per cent among the female
and 8.6 per cent among the male workers.
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Table. Serological results of health care personnel (male and female) of Aravind Eye Care System
Personnel No. examined IgG & IgM IgG positive & IgG & IgM
(male & negative IgM negative positive
female)
Physicians 31 (27+4) 5 26 0
Laboratory/research staff 12 (2+10) 2  8 2
Administrators/patient co-ordinators 71 (25+46) 7 61 3
Nurse/counsellor 274 (8+266) 39 227 8
Housekeeper/catering 73 (0+73) 3 68 2
Medical instrument production/repair staff 79 (11+68) 7 66 6
Opticians/refraction 37 (4+33) 3 33 1
X-ray/photography  4 (4+0) -  4 -
Total (%)  581                    66 (11.4)                493 (84.8)                22 (3.8%)
Rubella specific IgM antibody: Twenty two samples
were found to have both IgM and IgG antibodies for
rubella. To determine whether there would be
reduction in IgM positivity, samples were collected
four months later from these workers. The presence
of both anti-rubella IgM and IgG antibodies was
confirmed in the second samples. There was no
significant difference in the mean avidity indexes
(mean ± SD) between the first sample (79.8 ± 10.81)
and the second (82.5 ± 10.26) sample.
Immune status after vaccination: Among the 60
seronegative individuals three samples showed low
levels of anti-rubella IgG (4-9.6 IU/ml) and one a
fairly high level (74.3 IU/ml) when the same samples
were tested with Quantification assay. All 60
vaccinated volunteers were seropositive for IgG by
fourth week and the level of IgG antibody was more
than 20 IU/ml by third month, remaining at the same
level by sixth month (Fig.). IgM antibodies were
observed in 56 individuals by the fourth week and
15 individuals by sixth month after vaccination out
of 60 tested. In other words, 28 per cent of vaccinated
individuals remained positive for both anti-rubella
IgG and IgM antibodies even six months after
vaccination. Three out of four samples that showed
IgG antibody before vaccination in the quantification
assay were negative for IgM antibody after
vaccination.
Avidity index analysis for IgG revealed that the
levels of highly avid antibodies increased
progressively after immunization from the first
month to sixth month. A significant (P<0.001)
difference in the mean avidity index (mean ± SD)
was observed among the fourth week (9.2 ± 15.23),
third month (36.9 ± 12.20) and sixth month (58.2 ±
9.25) post vaccinated samples.
Discussion
Rubella is an infectious disease affecting all age
groups and both sexes18. Health care personnel
especially those without protective anti-rubella
antibodies are at high risk for rubella infection. To
prevent infection in susceptible employees and to
reduce the likelihood of nosocomial transmission to
patients and non-immune health care workers,
vaccination against rubella is necessary8,16. The
present study among the health care workers in an
eye hospital revealed 11.4 per cent to be of high risk
group. The major proportion of seronegativity was
observed between 15 and 19 yr of age among females
and 25-29 yr age group among males. This may be a
reflection of the population status for rubella
immunity in this part of the country.
Serosurveys conducted in 45 developing
countries in 199017 indicated that many women of
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Fig. IgG antibody profile in the healthcare workers after immunization with RA 27/3 monovalent rubella vaccine.
child bearing age living in developing countries
remain at risk for developing CRS in their infants.
In 2001, a serosurvey study conducted in New Delhi
among young school girls of age 9-12 yr attending
Paediatric outpatient department revealed 10 per cent
of seronegativity and vaccination provided
seroconversion completely19. In Amritsar district,
Punjab, India seroprevalence of rubella was
determined among 580 women by IgG antibody
analysis and 71.3 per cent were found to be
seropositive. This indicated that about one third of
women were susceptible to rubella infection14.
Similar to this 11.8 per cent of our study population
also exhibited susceptibility in the child bearing age
group.
Our study further revealed that 8.6 per cent of
male health care personnel were seronegative, thus
indicating the risk of transmission to the susceptible
women15. In a serosurvey study conducted among the
Nigerian and Swedish population, the rate of non-
immunity was higher in females than males and the
difference was not significant, possibly due to lower
number of male participants12. The present study
confirms the above findings.
The vaccine RA 27/3, administered to the
seronegative individuals is known to be highly
efficacious. In clinical trials done among 12 month
and older age group, 95-100 per cent of
seroconversion was observed by 21-28 days after
vaccination. With vaccination at 9 months of age,
more than 95 per cent of seroconversion was
reported17. In Thailand, during the serosurvey of
health care workers, the seronegative individuals
were vaccinated by RA 27/3 Wistar vaccine and 100
per cent seroconversion was observed11. According
to WHO, 10-12 IU/ml of IgG level is usually
satisfactory for serosurveys in enzyme
immunoassay7. In the present study, all the volunteers
immunized with RA 27/3 developed protective
immunity with the titre of more than 20 IU/ml and
high avidity within three months after vaccination,
thus confirming the above reports for India.
Rubella specific IgM antibodies were detectable
starting from the day 5-10 after infection and rose
rapidly around the day 20, proceeding to disappear
by the day 50-7020-22. In 1975, Pattison et al21 observed
the persistence of IgM antibody in 2 individuals out
of 13, more than 10 months after acute rubella
infection during the outbreak among the medical
students and nurses in London. In the present study,
persistence of IgM antibodies was also observed four
months after the first test and further there was no
change in the IgG avidity index between these two
samples. Similarly, the presence of IgM antibodies
even six months after vaccination was observed.
However, no explanation could be provided.
We have demonstrated that the seronegative
workers were not immunologically defective but
were capable of producing good protective immunity.
The avidity of rubella specific IgG antibody also
established a progressive increase in the maturation
of antibody from the first to sixth month after
vaccination. A similar study with all these parameters
needs to be conducted in different Indian populations.
It is evident from the present study that rubella
virus infection is prevalent in our population. Women
in childbearing age group without protective
immunity are highly susceptible in acquiring
infection. Since vaccination against rubella is not
mandatory in our country, there is a need to formulate
an effective rubella immunization programme
especially for the women of child bearing age group.
As the serological screening for anti-rubella IgG
antibody is very expensive, WHO recommends the
direct vaccination of all women in childbearing age
group since there is no harm in vaccinating already
immune individuals17.  Therefore it  may be
recommended that vaccinating the health care
workers against rubella at the beginning of their
employment would help to protect health care
personnel and also to prevent hospital based
outbreaks.
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